This training grant from the Center for Cell and Gene Therapy (CAGT) / Baylor College of Medicine provides a comprehensive training program for both predoctoral students and postdoctoral fellows with career research interests in cell and gene therapy - either its fundamental or clinical aspects, or both. The rationale is that a stimulating program of education and laboratory training from high quality mentors will attract promising candidates, including under-represented minorities, to this emerging field and increase the likelihood of their pursuing careers as members of translational research teams. Translational research is increasingly complex, and for advances to be efficiently implemented requires teams of investigators to collaborate and develop novel strategies that can be validated in the clinic. This type of translational research training requires the involvement of a dedicated team of mentors with diverse but complementary skills. The proposed training takes advantage of the outstanding biomedical curricula and experienced faculty within the Baylor system and the CAGT. A cadre of 27 faculty members with research interests in vector design and targeting, stem cell biology, molecular and cellular genetics, immunotherapy, gene therapy and stem cell transplantation, among other topics, will be available to mentor predoctoral students and both MD and PhD postdoctoral fellows at any given time). Major strengths of the program are (1) its targeting of rigorous basic biomedical science and clinical research training toward a translational goal;(2) its strong reliance on the proven scientific excellence of cell biology and genetics research training programs at Baylor, and (3) its involvement of mentors, including the program director and co directors, who have a wealth of experience in translational research and in training young investigators (4) availability of unique resources such as the GMP laboratories for training. Augmenting the formal course work and laboratory training will be opportunities to present recent research findings at annual retreats sponsored by the CAGT and academic departments within Baylor. During the first 4 years of funding this approach has successfully trained 8 graduate students and 1 post doctoral fellows in translational cell and gene therapy research, all of whom are continuing in academic careers. The maintenance of support will allow us to continue to provide trainees with a strong foundation for translational research careers in this emerging area.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Institutional National Research Service Award (T32)
Project #
5T32HL092332-10
Application #
8296335
Study Section
NHLBI Institutional Training Mechanism Review Committee (NITM)
Program Officer
Welniak, Lisbeth A
Project Start
2003-07-01
Project End
2013-06-30
Budget Start
2012-07-01
Budget End
2013-06-30
Support Year
10
Fiscal Year
2012
Total Cost
$248,781
Indirect Cost
$20,328
Name
Baylor College of Medicine
Department
Pediatrics
Type
Schools of Medicine
DUNS #
051113330
City
Houston
State
TX
Country
United States
Zip Code
77030
Rouce, R H; Shaim, H; Sekine, T et al. (2016) The TGF-β/SMAD pathway is an important mechanism for NK cell immune evasion in childhood B-acute lymphoblastic leukemia. Leukemia 30:800-11
Rosewell Shaw, Amanda; Suzuki, Masataka (2016) Recent advances in oncolytic adenovirus therapies for cancer. Curr Opin Virol 21:9-15
Pankowicz, Francis P; Barzi, Mercedes; Legras, Xavier et al. (2016) Reprogramming metabolic pathways in vivo with CRISPR/Cas9 genome editing to treat hereditary tyrosinaemia. Nat Commun 7:12642
Rouce, Rayne H; Heslop, Helen E (2016) Forecasting Cytokine Storms with New Predictive Biomarkers. Cancer Discov 6:579-80
Bonifant, Challice L; Szoor, Arpad; Torres, David et al. (2016) CD123-Engager T Cells as a Novel Immunotherapeutic for Acute Myeloid Leukemia. Mol Ther 24:1615-26
Rouce, Rayne H; Sharma, Sandhya; Huynh, Mai et al. (2016) Recent advances in T-cell immunotherapy for haematological malignancies. Br J Haematol :
Hegde, Meenakshi; Mukherjee, Malini; Grada, Zakaria et al. (2016) Tandem CAR T cells targeting HER2 and IL13Rα2 mitigate tumor antigen escape. J Clin Invest 126:3036-52
Chang, Edmund C; Liu, Hao; West, John A et al. (2016) Clonal Dynamics In Vivo of Virus Integration Sites of T Cells Expressing a Safety Switch. Mol Ther 24:736-45
Gundry, Michael C; Brunetti, Lorenzo; Lin, Angelique et al. (2016) Highly Efficient Genome Editing of Murine and Human Hematopoietic Progenitor Cells by CRISPR/Cas9. Cell Rep 17:1453-1461
Hanley, Patrick J; Melenhorst, Jan J; Nikiforow, Sarah et al. (2015) CMV-specific T cells generated from naïve T cells recognize atypical epitopes and may be protective in vivo. Sci Transl Med 7:285ra63

Showing the most recent 10 out of 104 publications